Management ChangeJul 7, 2026, 07:02 AM
ImageneBio Appoints Matt Robbins as General Counsel
AI Summary
ImageneBio, Inc. announced the appointment of Matt Robbins as General Counsel, effective July 7, 2026. Robbins, an experienced life sciences attorney with over 15 years of corporate, securities, and transactional experience, will oversee the company's legal, corporate governance, intellectual property, and compliance functions. This strategic hire is intended to support ImageneBio as it advances its lead candidate, IMG-007, through Phase 2 clinical programs in atopic dermatitis and alopecia areata, entering a new phase of growth.
Key Highlights
- ImageneBio appointed Matt Robbins as General Counsel, effective July 7, 2026.
- Robbins brings over 15 years of corporate, securities, and transactional experience.
- He will oversee legal, corporate governance, intellectual property, and compliance functions.
- Previously, Robbins served as General Counsel of Bright Peak Therapeutics, Inc.
- ImageneBio is advancing its lead candidate, IMG-007, in Phase 2 clinical programs.
Price Impact
More from IMA